Hint mode is switched on Switch off
For swift navigation between sections

BIOTON
LEI 259400I5R1L3OPCGII81

Organization name
BIOTON S.A.
Country name
Poland
Country of registration
Poland
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • Eurorating
    ***
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

BIOTON aims to reinforce its position of a biotechnological company with a global reach. The Company is able to pursue its strategic objectives of protecting Patients’ health and improving the quality of their lives by participating in research and development projects, promoting the expansion of its product portfolio and making well-informed business decisions.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    259400I5R1L3OPCGII81
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Registration is required to get access.